Increased In-Hospital Mortality in Immunocompromised Individuals Hospitalized With COVID-19 During the Global Pandemic: A Multinational Cohort Study in the EuCARE Project
The Journal of Infectious Diseases · 2026
DOI: 10.1093/infdis/jiag254 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift The Journal of Infectious Diseases, 2026. Verfasst von Ashley O Roen und 15 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Clinical Research, Epidemiology, Modelling and Evaluation, Institute for Global Health, University College London, London, United Kingdom. Hauptthemen laut MEDLINE: COVID-19, Hospital Mortality, Immunocompromised Host. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union´s Horizon Europe Research and Innovation Programme.
Abstract (Originalsprache)
Background
Although coronavirus disease 2019 (COVID-19) is no longer a public health emergency, it remains the most prevalent circulating infectious-like illness in Europe. Whether immunocompromising conditions (ICCs) still carry increased mortality risk during the Omicron era is unclear.
Methods
We conducted a cohort study across EuCARE sites in 8 countries among adults admitted to hospital with COVID-19 between 2020 and 2023. ICCs and COVID-19 pneumonia at hospitalization were defined using clinical information and ICD-10 codes. Logistic regression and counterfactual mediation analysis was used to compare 28-day in-hospital mortality risk associated with ICCs using COVID-19 pneumonia and vaccination at hospital entry as intermediates. Proportion of the total effect of ICCs mediated and the controlled direct effects (CDEs) were calculated. We also formally tested for interaction between SARS-CoV-2 variants and ICCs for mortality risk.
Results
A total of 42 488 individuals were included, of whom 1675 (3.9%) had an ICC. Fifty-five percent were male, and the median age was 67 (IQR, 52–79) years. Overall, 4344 (10.2%) individuals died in hospital. ICCs were associated with increased mortality (OR, 1.49 [95% CI, 1.25–1.79]), with no evidence for an attenuation during the Omicron phase (P value for interaction = .60). Mediation analyses showed that the total effect of ICCs was mediated by vaccination but only weakly by pneumonia. With Omicron, the excess mortality associated with ICC was higher under the scenario that everyone in the cohort was to develop COVID-19 pneumonia (CDE, 1.22 [95% CI, .09–1.65]).
Conclusions
ICC remains a significant risk factor for in-hospital death, even during the Omicron era, particularly if the infection led to the development of pneumonia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Centre for Clinical Research, Epidemiology, Modelling and Evaluation, Institute for Global Health, University College London, London, United Kingdom.
- Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden.
- Department of Gastroenterology, Hepatology and Infectious Diseases, Medical Faculty and University Hospital Duesseldorf, Heinrich Heine University, Duesseldorf, Germany.
- Department of Medical Biotechnologies, University of Siena, Siena, Italy.
- Vilnius Santaros Klinikos Biobank, Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania.
- Department of Infectious, Tropical Diseases and Acquired Immunodeficiency, Pomeranian Medical University, Szczecin, Poland.
ORCID-Profile: Ashley O Roen, Pontus Hedberg, Joana P Ventura Pereira, Dovile Juozapaite, João Domingos, Giulia Marchetti, Luca Carioti, Anders Sönnerborg, Björn-Erik Ole Jensen, Francesca Incardona, Alessandro Cozzi-Lepri
Förderung
- European Union´s Horizon Europe Research and Innovation Programme
Zitieren
APA
Roen, A. O., Hedberg, P., Pereira, J. P. V., Zazzi, M., Juozapaite, D., Parczewski, M., Domingos, J., Drobniewski, F., Marchetti, G., Carioti, L., Nauclér, P., Sönnerborg, A., Jensen, B. O., Incardona, F., Cozzi-Lepri, A., & European cohorts of patients and schools to advance response to epidemics (EuCARE) Project (2026). Increased In-Hospital Mortality in Immunocompromised Individuals Hospitalized With COVID-19 During the Global Pandemic: A Multinational Cohort Study in the EuCARE Project. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiag254
Vancouver
Roen AO, Hedberg P, Pereira JPV, Zazzi M, Juozapaite D, Parczewski M, et al. Increased In-Hospital Mortality in Immunocompromised Individuals Hospitalized With COVID-19 During the Global Pandemic: A Multinational Cohort Study in the EuCARE Project. The Journal of Infectious Diseases. 2026. doi:10.1093/infdis/jiag254
BibTeX
@article{Roen2026,
author = {Roen, Ashley O and Hedberg, Pontus and Pereira, Joana P Ventura and Zazzi, Maurizio and Juozapaite, Dovile and Parczewski, Milosz and Domingos, João and Drobniewski, Francis and Marchetti, Giulia and Carioti, Luca and Nauclér, Pontus and Sönnerborg, Anders and Jensen, Björn-Erik Ole and Incardona, Francesca and Cozzi-Lepri, Alessandro and European cohorts of patients and schools to advance response to epidemics (EuCARE) Project, European cohorts of patients and schools to advance response to epidemics (EuCARE) Project},
title = {Increased In-Hospital Mortality in Immunocompromised Individuals Hospitalized With COVID-19 During the Global Pandemic: A Multinational Cohort Study in the EuCARE Project},
journal = {The Journal of Infectious Diseases},
year = {2026},
doi = {10.1093/infdis/jiag254}
}
EUVIMED